Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Käyhty

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Expert Review of Vaccines|August 7, 2003
Evolution of conjugate vaccinesP Helena Mäkelä, Helena Käyhty
The Lancet. Infectious Diseases|February 22, 2015
Applied public health research on the frontlineArto A Palmu, Helena Käyhty
The Journal of Infectious Diseases|October 2, 2002
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in childrenBirgit Simell, Terhi M Kilpi, Helena Käyhty
Leukemia & Lymphoma|May 29, 2003
Vaccination against infections in chronic lymphocytic leukemiaMarjatta Sinisalo, Janne Aittoniemi, Helena Käyhty, et al.
Infection and Immunity|April 20, 2006
Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant ratsMaija Toropainen, Leena Saarinen, Gestur Vidarsson, et al.
Leukemia & Lymphoma|December 17, 2002
Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for responseMarjatta Sinsalo, Janne Aittoniemi, Helena Käyhty, et al.
Vaccine|November 9, 2004
Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine TrialAnu Nurkka, Mika Lahdenkari, Arto Palmu, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2008
Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteinsBirgit Simell, Mika Lahdenkari, Antti Reunanen, et al.
Vaccine|August 24, 2005
Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriageEmma Holmlund, Beatriz Quiambao, Jukka Ollgren, et al.
The Pediatric Infectious Disease Journal|February 11, 2005
Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of ageHelena Käyhty, Heidi Ahman, Karin Eriksson, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Expert Review of Vaccines|August 7, 2003
Evolution of conjugate vaccinesP Helena Mäkelä, Helena Käyhty
The Lancet. Infectious Diseases|February 22, 2015
Applied public health research on the frontlineArto A Palmu, Helena Käyhty
The Journal of Infectious Diseases|October 2, 2002
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in childrenBirgit Simell, Terhi M Kilpi, Helena Käyhty
Leukemia & Lymphoma|May 29, 2003
Vaccination against infections in chronic lymphocytic leukemiaMarjatta Sinisalo, Janne Aittoniemi, Helena Käyhty, et al.
Infection and Immunity|April 20, 2006
Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant ratsMaija Toropainen, Leena Saarinen, Gestur Vidarsson, et al.
Leukemia & Lymphoma|December 17, 2002
Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for responseMarjatta Sinsalo, Janne Aittoniemi, Helena Käyhty, et al.
Vaccine|November 9, 2004
Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine TrialAnu Nurkka, Mika Lahdenkari, Arto Palmu, et al.
Clinical and Vaccine Immunology : CVI|July 4, 2008
Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteinsBirgit Simell, Mika Lahdenkari, Antti Reunanen, et al.
Vaccine|August 24, 2005
Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriageEmma Holmlund, Beatriz Quiambao, Jukka Ollgren, et al.
The Pediatric Infectious Disease Journal|February 11, 2005
Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of ageHelena Käyhty, Heidi Ahman, Karin Eriksson, et al.
Pageof 9